Efluelda susp inj 2025/2026 ser pré 0.7 ml
7680677040283
CH-67704
J07BB02
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
60.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.72 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 48.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2025
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67704
- Drug name
- Efluelda, suspension injectable en seringue préremplie
- Galenic form
- INJFS
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/07/2021
- Authorization expiration date
- 20/07/2026
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EFLUELDA 0.7 ml sol inj 60 µg 1 pce
- Description (DE)
- EFLUELDA 0.7 ml Inj Lös 60 µg 1 Stk
- Market launch
- 11/04/2025
- Narcotic (BTM)
- No